Research Articles

Blossom covers the latest that goes on with psychedelic research. We make the waterfall of new papers easier to digest, for both laypeople, psychedelic entrepreneurs, and researchers alike. We provide handy overview posts every month and research highlights every second week.

Need an overview of where the research stands at this moment? Dive in with our Research Overview.

Integration of psychedelic experiences can be key | How the integration after psychedelics can be vital for positive therapeutic outcomes
Category: Top Papers
Published: 2022-01-11
In the Research Briefing of January 10th: 1) Psilocybin can be administered safely for up to six people simultaneously 2) An Open Science approach toward MDMA synthesis 3) Nitrous Oxide could be the next antidepressant
Category: Briefings
Published: 2022-01-10
This is all the other psychedelic research that came out in January 2022.
Category: Links
Published: 2022-01-05
December was another busy month in the world of psychedelic research as 2021 came to a close. The benefits of microdosing remain in dispute, the use of virtuality reality in tandem with psychedelics is further discussed, while we simultaneously gained further insight as to how different psychedelics work in the brain for different disorders, through both experiments and reviews.
Category: Overviews
Published: 2022-01-04
In the Research Briefing of December 20th: 1) New double-blind study doesn't find benefits of microdosing 2) The negative post-acute effects of MDMA appear to be absent in the clinical setting
Category: Briefings
Published: 2021-12-17
To better understand the science of psychedelics, and how we can make the bridge to implementing them in practice, Blossom is conducting a series of interviews with psychedelic scientists. Our editor-at-large, George Fejer, speaks to David Glowacki, one of the world's leaders in the use of virtual reality applied to scientific simulation and visualization.
Category: Research
Published: 2021-12-13
Microdosing is becoming more popular every day. From Hollywood to small towns all across the word. Is there scientific merit to it, or all placebo? And does a new paper prove the benefits of microdosing?
Category: Column
Published: 2021-12-10
November proved to be another productive month for psychedelic research. A variety of surveys looked at how psychedelics alter beliefs, reduce opioid use, and the effects of microdosing. A finished Phase I trial clear 5-MeO-DMT for the next step, cannabis intensifies a psychedelic experience, and psychedelics may help with Alzheimer's.
Category: Overviews
Published: 2021-12-08
In the Research Briefing of December 6th: 1) The methodological challenges faced in psychedelic clinical trials (and how to fix them) 2) Mystical experiences in recreational use associated with improvements in wellbeing 3) A novel 5-MeO-DMT formulation proves to be safe in Phase I trial
Category: Briefings
Published: 2021-12-06
This is all the other psychedelic research that came out in December 2021.
Category: Links
Published: 2021-12-06

Research Articles

Blossom‘s articles cover everything from the latest paper (also featured individually in our Papers Database) to analyses of research fields. From MDMA-AT for PTSD to psilocybin for TRD. We will pick apart the industry terms, e.g. MDMA-AT = MDMA-assisted therapy

Become a psychedelic insider!

With a free Blossom membership you will always be in the know.

📰 Weekly newsletter about the psychedelic research

✔️ Unlimited access to our database and original articles

🖊️ Add (private) notes and comments to each page

Make an account